Core Scientific (CORZ) Gross Margin (2021 - 2026)

Core Scientific has disclosed Gross Margin across 6 years of filings, most recently posting 42.66% for Q2 2026.

• In Q2 2026, Gross Margin rose 3627.0% year-over-year to 42.66%; the TTM figure through Jun 2026 stood at 28.35% (up 2322.0% YoY), while the FY2025 annual figure was 11.88%, down 1183.0% from the prior year.
• Gross Margin came in at 42.66% for Q2 2026 at Core Scientific, up from 26.12% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 43.31% in Q1 2024 to a low of 38.96% in Q4 2022.
• Average Gross Margin over 5 years is 15.41%, with a median of 19.84% recorded in 2025.
• Year-over-year, Gross Margin slumped 8581 bps in 2022 and surged 6665 bps in 2023.
• Over 5 years, Gross Margin stood at 38.96% in 2022, then surged by 171 bps to 27.69% in 2023, then tumbled by 82 bps to 5.02% in 2024, then surged by 419 bps to 26.02% in 2025, then jumped by 64 bps to 42.66% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 42.66% in Q2 2026, 26.12% in Q1 2026, and 26.02% in Q4 2025.